CT-based radiomics and intratumoral heterogeneity for predicting benign and malignant lesions in solid pulmonary nodules.
1/5 보강
[BACKGROUND] Lung cancer remains one of the leading causes of cancer-related deaths worldwide.
- 표본수 (n) 34
- 95% CI 0.773-0.890
APA
Lv Y, Zhang M, et al. (2026). CT-based radiomics and intratumoral heterogeneity for predicting benign and malignant lesions in solid pulmonary nodules.. Journal of thoracic disease, 18(1), 11. https://doi.org/10.21037/jtd-2025-1869
MLA
Lv Y, et al.. "CT-based radiomics and intratumoral heterogeneity for predicting benign and malignant lesions in solid pulmonary nodules.." Journal of thoracic disease, vol. 18, no. 1, 2026, pp. 11.
PMID
41660460
Abstract
[BACKGROUND] Lung cancer remains one of the leading causes of cancer-related deaths worldwide. This study utilized clinical risk factors along with intratumoral radiomics, peritumoral radiomics, and intratumoral subregional features extracted from computed tomography (CT) lung-window images for individual and integrated modeling to classify solid pulmonary nodules and identify the optimal model, thereby improving diagnostic accuracy while minimizing unnecessary invasive procedures.
[METHODS] CT images of 230 pathologically confirmed solitary solid pulmonary nodules were retrospectively collected from two hospitals. Among the 167 patients from the first hospital, 20% (n=34) served as the test set, while the remaining 80% (n=133) were used as the training and development set for 5-fold cross-validation, while data from the second hospital (n=63) served as an external test set. Intratumoral and peritumoral regions of interest (ROIs) were delineated on lung window images, and relevant radiomics features were extracted. Multiple machine learning algorithms-including Logistic Regression (LR), Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and Linear Support Vector Classifier (Linear SVC) etc.-were employed to construct predictive models for distinguishing benign from malignant solid pulmonary nodules.
[RESULTS] A triple-feature model (intratumoral, peritumoral, clinical) achieved superior diagnostic performance [area under the receiver operating characteristic curve (AUC): training 0.932, 95% confidence interval (CI): 0.897-0.960; test 0.833, 95% CI: 0.773-0.890; external test 0.741, 95% CI: 0.618-0.864] with high sensitivity/specificity. The intratumoral-peritumoral dual-modality model showed optimal cross-center robustness external test, AUC =0.808 (95% CI: 0.700-0.922). Habitat imaging revealed heterogeneity, AUC =0.750 (95% CI: 0.676-0.825). Decision curve analysis confirmed the triple-model's clinical utility. SHAP identified age, gender, and key radiomics (e.g., gradient_firstorder_Skewness_Intra) as top predictors. Multi-center test confirmed generalizability, positioning this integrated framework as a robust tool to reduce invasive procedures in pulmonary nodule management.
[CONCLUSIONS] The multi-combination models developed in this study enhance the diagnostic accuracy for distinguishing benign from malignant solid pulmonary nodules, with the triple-feature model demonstrating the highest diagnostic performance. This approach has the potential to spare patients from unnecessary invasive procedures and strengthen clinical decision-making in the management of pulmonary nodules.
[METHODS] CT images of 230 pathologically confirmed solitary solid pulmonary nodules were retrospectively collected from two hospitals. Among the 167 patients from the first hospital, 20% (n=34) served as the test set, while the remaining 80% (n=133) were used as the training and development set for 5-fold cross-validation, while data from the second hospital (n=63) served as an external test set. Intratumoral and peritumoral regions of interest (ROIs) were delineated on lung window images, and relevant radiomics features were extracted. Multiple machine learning algorithms-including Logistic Regression (LR), Support Vector Machine (SVM), K-Nearest Neighbors (KNN), and Linear Support Vector Classifier (Linear SVC) etc.-were employed to construct predictive models for distinguishing benign from malignant solid pulmonary nodules.
[RESULTS] A triple-feature model (intratumoral, peritumoral, clinical) achieved superior diagnostic performance [area under the receiver operating characteristic curve (AUC): training 0.932, 95% confidence interval (CI): 0.897-0.960; test 0.833, 95% CI: 0.773-0.890; external test 0.741, 95% CI: 0.618-0.864] with high sensitivity/specificity. The intratumoral-peritumoral dual-modality model showed optimal cross-center robustness external test, AUC =0.808 (95% CI: 0.700-0.922). Habitat imaging revealed heterogeneity, AUC =0.750 (95% CI: 0.676-0.825). Decision curve analysis confirmed the triple-model's clinical utility. SHAP identified age, gender, and key radiomics (e.g., gradient_firstorder_Skewness_Intra) as top predictors. Multi-center test confirmed generalizability, positioning this integrated framework as a robust tool to reduce invasive procedures in pulmonary nodule management.
[CONCLUSIONS] The multi-combination models developed in this study enhance the diagnostic accuracy for distinguishing benign from malignant solid pulmonary nodules, with the triple-feature model demonstrating the highest diagnostic performance. This approach has the potential to spare patients from unnecessary invasive procedures and strengthen clinical decision-making in the management of pulmonary nodules.
🏷️ 키워드 / MeSH
같은 제1저자의 인용 많은 논문 (5)
- KRAS mutations reshape the immunosuppressive tumor microenvironment in triple-negative breast cancer: A novel perspective.
- The roles and pathways of Hsa_circ_0000285 in cancer: a potential target for cancer therapy.
- Promotion of lung cancer growth via glutamate ionotropic receptor N-methyl-D-aspartate-type subunit 2D ().
- Redefining the role of carbon nanoparticles in colorectal cancer surgery: From lymph node yield to diagnostic paradox.
- FAPI-Negative but FDG-Avid Hepatocellular Carcinoma With Extensive Steatosis.